# Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

> **NCT00361595** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 35 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00361595
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361595, "Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00361595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*